These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38227697)

  • 1. Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study.
    Tebaldi M; Campo G; Ugo F; Guarracini S; Marrone A; Clò S; Abdirashid M; Di Mauro M; Rametta F; Di Marco M; Cocco M; Marchini F; Penzo C; Erriquez A; Banai S; Biscaglia S
    Circ Cardiovasc Interv; 2024 Jan; 17(1):e013481. PubMed ID: 38227697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience.
    Giannini F; Baldetti L; Ponticelli F; Ruparelia N; Mitomo S; Latib A; Montorfano M; Jabbour RJ; Aurelio A; Ferri L; Mangieri A; Regazzoli D; Ancona M; Pagnesi M; Faccini A; Chieffo A; Azzalini L; Carlino M; Colombo A
    JACC Cardiovasc Interv; 2018 Apr; 11(8):784-792. PubMed ID: 29673511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.
    Jolicœur EM; Banai S; Henry TD; Schwartz M; Doucet S; White CJ; Edelman E; Verheye S
    Trials; 2013 Feb; 14():46. PubMed ID: 23413981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study.
    Banai S; Ben Muvhar S; Parikh KH; Medina A; Sievert H; Seth A; Tsehori J; Paz Y; Sheinfeld A; Keren G
    J Am Coll Cardiol; 2007 May; 49(17):1783-9. PubMed ID: 17466229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina.
    Jolicoeur EM; Verheye S; Henry TD; Joseph L; Doucet S; White CJ; Edelman E; Banai S
    Heart; 2021 Jan; 107(1):41-46. PubMed ID: 32719097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of coronary sinus narrowing on diastolic function in patients with refractory angina.
    Szekely Y; Topilsky Y; Bazan S; Revivo M; Banai S; Konigstein M
    Int J Cardiol; 2019 Sep; 291():8-12. PubMed ID: 30979603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris.
    Tzanis G; Palmisano A; Gallone G; Ponticelli F; Baldetti L; Esposito A; Colombo A; Giannini F
    Catheter Cardiovasc Interv; 2020 May; 95(6):1104-1108. PubMed ID: 31373415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
    Konigstein M; Ponticelli F; Zivelonghi C; Merdler I; Revivo M; Verheye S; Giannini F; Banai S
    Clin Cardiol; 2021 Mar; 44(3):424-428. PubMed ID: 33605473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study.
    Palmisano A; Giannini F; Rancoita P; Gallone G; Benedetti G; Baldetti L; Tzanis G; Vignale D; Monti C; Ponticelli F; Ancona M; Montorfano M; Del Maschio A; De Cobelli F; Colombo A; Esposito A
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):291-303. PubMed ID: 32860122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of the reducer: A multi-center clinical registry - REDUCE study.
    Giannini F; Baldetti L; Konigstein M; Rosseel L; Ruparelia N; Gallone G; Colombo A; Banai S; Verheye S
    Int J Cardiol; 2018 Oct; 269():40-44. PubMed ID: 29983248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study).
    Verheye S; Agostoni P; Giannini F; Hill JM; Jensen C; Lindsay S; Stella PR; Redwood S; Banai S; Konigstein M
    EuroIntervention; 2021 Sep; 17(7):561-568. PubMed ID: 33319762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors.
    Collison D; Copt S; Mizukami T; Collet C; McLaren R; Didagelos M; Aetesam-Ur-Rahman M; McCartney P; Ford TJ; Lindsay M; Shaukat A; Rocchiccioli P; Brogan R; Watkins S; McEntegart M; Good R; Robertson K; O'Boyle P; Davie A; Khan A; Hood S; Eteiba H; Berry C; Oldroyd KG
    Circ Cardiovasc Interv; 2023 Apr; 16(4):e012511. PubMed ID: 36974680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a device to narrow the coronary sinus in refractory angina.
    Verheye S; Jolicœur EM; Behan MW; Pettersson T; Sainsbury P; Hill J; Vrolix M; Agostoni P; Engstrom T; Labinaz M; de Silva R; Schwartz M; Meyten N; Uren NG; Doucet S; Tanguay JF; Lindsay S; Henry TD; White CJ; Edelman ER; Banai S
    N Engl J Med; 2015 Feb; 372(6):519-27. PubMed ID: 25651246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of coronary sinus reducer in patients with refractory angina-A systematic review of the literature.
    Bazoukis G; Brilakis ES; Tse G; Letsas KP; Kitsoulis P; Liu T; Baranchuk A; Sideris A; Tsioufis C; Stavrakis S
    J Interv Cardiol; 2018 Dec; 31(6):775-779. PubMed ID: 30191622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience.
    Konigstein M; Bazan S; Revivo M; Banai S
    EuroIntervention; 2018 Jul; 14(4):e452-e458. PubMed ID: 29688178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary sinus narrowing therapy: A "Reducer" for angina and beyond.
    Dimitriadis K; Iliakis P; Pyrpyris N; Beneki E; Tsioufis P; Aznaouridis K; Aggeli K; Tsioufis K
    Cardiovasc Revasc Med; 2023 Dec; 57():96-105. PubMed ID: 37573172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Microcirculation Response Between Culprit and Non-Culprit Vessels in Patients With Acute Coronary Syndrome.
    Jo YS; Moon H; Park K
    J Am Heart Assoc; 2020 May; 9(10):e015507. PubMed ID: 32410526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries.
    Corban MT; Toya T; Albers D; Sebaali F; Lewis BR; Bois J; Gulati R; Prasad A; Best PJM; Bell MR; Rihal CS; Prasad M; Ahmad A; Lerman LO; Solseth ML; Winters JL; Dietz AB; Lerman A
    Circ Res; 2022 Feb; 130(3):326-338. PubMed ID: 34923853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.
    Ford TJ; Yii E; Sidik N; Good R; Rocchiccioli P; McEntegart M; Watkins S; Eteiba H; Shaukat A; Lindsay M; Robertson K; Hood S; McGeoch R; McDade R; McCartney P; Corcoran D; Collison D; Rush C; Stanley B; McConnachie A; Sattar N; Touyz RM; Oldroyd KG; Berry C
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008126. PubMed ID: 31833416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
    Fearon WF; Zimmermann FM; Ding VY; Zelis JM; Piroth Z; Davidavicius G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Oldroyd KG; Wendler O; Reardon MJ; Woo YJ; Yeung AC; Pijls NHJ; De Bruyne B; Desai M; Hlatky MA;
    Circulation; 2022 May; 145(22):1655-1662. PubMed ID: 35369704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.